EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systems Pharmacology and Multi-Omics Elucidation of Irpex lacteus Polysaccharides in the Treatment of Lupus Nephritis Through PI3K/AKT/NF-κB Pathway Inhibition

Guoxin Ji, Zhuangzhuang Yao, Yuetong Zhao, Cuicui Li iD, Bo Yang, Zhimeng Li, Mingfang Kuang, He Wang, Xian Wu, Huiyang Yuan, Yue Deng, Shumin Wang iD und 1 weitere

Pharmaceuticals · 27.10.2025 · 18 (11) · 1619

DOI: 10.3390/ph18111619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 27.10.2025. Verfasst von Guoxin Ji und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Program Project of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), necessitates effective therapeutic strategies. Polysaccharides derived from Irpex lacteus have demonstrated beneficial biological activities in MRL/lpr mice; however, their precise mechanisms of intervention in LN require further elucidation.

Methods

MRL/lpr mice were administered low-dose and high-dose Irpex lacteus polysaccharide (PCP) continuously for 8 weeks. The therapeutic efficacy of PCP was systematically assessed by measuring autoantibody levels, inflammatory cytokine expression, and renal function markers. The underlying pharmacological mechanisms were investigated through integrated transcriptomics and metabolomics analyses.

Results

PCP treatment significantly improved renal function in MRL/lpr mice, normalizing serum levels of anti-nuclear antibodies (ANA), anti-double-stranded DNA antibodies (anti-dsDNA), anti-Sm antibody (Sm), creatinine (Cr), blood urea nitrogen (BUN), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and proteinuria. Integrated transcriptomic and metabolomic analyses revealed that the therapeutic action of PCP involves modulation of the PI3K/AKT/NF-κB pathway. This inhibition was further confirmed by Western blot analysis.

Conclusions

PCP exerts renal protective effects in MRL/lpr mice by mitigating inflammation, modulating immune responses, and preserving renal function. The combined application of transcriptomics, metabolomics, and Western blotting elucidates that this protection is mediated through inhibition of the PI3K/AKT/NF-κB signaling pathway.

Schlagwörter

Stichwörter der Autor:innen

Irpex lacteus polysaccharidesPI3K/AKT/NF-κB signaling pathwaylupus nephritismetabolomicssystemic lupus erythematosustranscriptomics

Autor:innen und Institutionen

  • College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
  • College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
  • College of Integrated Chinese and Western Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
  • Ginseng Scientific Research Institute, Changchun University of Chinese Medicine, Changchun 130117, China.

ORCID-Profile: Cuicui Li, Shumin Wang, Huan Wang

Förderung

  • Science and Technology Development Program Project of Jilin Province

Zitieren

APA

Ji, G., Yao, Z., Zhao, Y., Li, C., Yang, B., Li, Z., Kuang, M., Wang, H., Wu, X., Yuan, H., Deng, Y., Wang, S., & Wang, H. (2025). Systems Pharmacology and Multi-Omics Elucidation of Irpex lacteus Polysaccharides in the Treatment of Lupus Nephritis Through PI3K/AKT/NF-κB Pathway Inhibition. Pharmaceuticals, 18(11), 1619. https://doi.org/10.3390/ph18111619

Vancouver

Ji G, Yao Z, Zhao Y, Li C, Yang B, Li Z, et al. Systems Pharmacology and Multi-Omics Elucidation of Irpex lacteus Polysaccharides in the Treatment of Lupus Nephritis Through PI3K/AKT/NF-κB Pathway Inhibition. Pharmaceuticals. 2025;18(11):1619. doi:10.3390/ph18111619

BibTeX
@article{Ji2025,
  author = {Ji, Guoxin and Yao, Zhuangzhuang and Zhao, Yuetong and Li, Cuicui and Yang, Bo and Li, Zhimeng and Kuang, Mingfang and Wang, He and Wu, Xian and Yuan, Huiyang and Deng, Yue and Wang, Shumin and Wang, Huan},
  title = {Systems Pharmacology and Multi-Omics Elucidation of Irpex lacteus Polysaccharides in the Treatment of Lupus Nephritis Through PI3K/AKT/NF-κB Pathway Inhibition},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {11},
  pages = {1619},
  doi = {10.3390/ph18111619}
}
Kostenlos starten →